Geeta Ram

Title: Geeta Ram: Innovator in Non-Antibiotic Treatments for Bacterial Infections

Introduction

Geeta Ram is a notable inventor based in Woodside, NY (US). She has made significant contributions to the field of microbiology, particularly in developing innovative methods for treating bacterial infections without the use of traditional antibiotics. Her work focuses on disrupting bacterial genes involved in virulence or viability, paving the way for new therapeutic approaches.

Latest Patents

Geeta Ram holds a patent for her invention titled "Compositions and methods for non-antibiotic treating of bacterial infections by blocking or disrupting bacterial genes involved in virulence or viability." This patent describes modified pathogenicity islands that include a polynucleotide comprising a bacterial pathogenicity island nucleotide sequence (B-PINS) with specific modifications. These modifications involve the deletion or disruption of virulence determinants and the insertion of cargo sequences. The polynucleotide can be packaged within a bacterium into a phage-like particle known as an antibacterial drone (ABD). The ABD is designed to infect bacteria, introducing cargo sequences that can modify or kill the bacteria. Additionally, the patent includes pharmaceutical compositions and methods for utilizing ABDs in bacterial treatment.

Career Highlights

Geeta Ram is affiliated with New York University, where she continues her research and development in the field of bacterial infections. Her innovative approach to non-antibiotic treatments has garnered attention in the scientific community, highlighting her role as a leading inventor in this area.

Collaborations

Geeta has collaborated with notable colleagues, including Richard P. Novick and Hope Forer Ross, who have contributed to her research endeavors. Their combined expertise has further advanced the understanding and application of her inventions.

Conclusion

Geeta Ram's work represents a significant advancement in the fight against bacterial infections, offering promising alternatives to traditional antibiotic treatments. Her innovative inventions and collaborations continue to shape the future of microbiological research and therapeutic development.